Last 12 months
Inside the activity.
0 purchase rows · 15 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 1 |
| Dec 2025 | 0 | 0 |
| Jan 2026 | 0 | 0 |
| Feb 2026 | 0 | 6 |
| Mar 2026 | 0 | 0 |
| Apr 2026 | 0 | 0 |
| May 2026 | 0 | 1 |
| Jun 2026 | 0 | 2 |
| Jul 2026 | 0 | 1 |
| Aug 2026 | 0 | 1 |
| Sep 2026 | 0 | 2 |
| Oct 2026 | 0 | 1 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| January 31, 2025 Filed Feb 4, 2025 16:53 UTC |
Schoenberg MarkChief Medical Officer
|
SaleOrdinary Shares | 1,896 | $11.14 | $21,121.44 |
DisclosureSEC source: 0001437749-25-002688 · rdgdoc.xml · nonDerivative · entry 4 Schoenberg Mark · CIK 0001763581 · Chief Medical Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 147,103 F2 · shares: Represents shares sold to satisfy withholding tax obligations upon the settlement of restricted stock units. Read SEC document |
| January 31, 2025 Filed Feb 4, 2025 16:53 UTC |
Schoenberg MarkChief Medical Officer
|
Exercise / conversionOrdinary Shares | 3,333 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001437749-25-002688 · rdgdoc.xml · nonDerivative · entry 3 Schoenberg Mark · CIK 0001763581 · Chief Medical Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 148,999 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each restricted stock unit ("RSU") represents a contingent right to receive one ordinary share of the Issuer. Read SEC document |
| January 31, 2025 Filed Feb 4, 2025 16:53 UTC |
Schoenberg MarkChief Medical Officer
|
SaleOrdinary Shares | 759 | $11.14 | $8,455.26 |
DisclosureSEC source: 0001437749-25-002688 · rdgdoc.xml · nonDerivative · entry 2 Schoenberg Mark · CIK 0001763581 · Chief Medical Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 145,666 F2 · shares: Represents shares sold to satisfy withholding tax obligations upon the settlement of restricted stock units. Read SEC document |
| January 31, 2025 Filed Feb 4, 2025 16:53 UTC |
Schoenberg MarkChief Medical Officer
|
Exercise / conversionOrdinary Shares | 1,334 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001437749-25-002688 · rdgdoc.xml · nonDerivative · entry 1 Schoenberg Mark · CIK 0001763581 · Chief Medical Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 146,425 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each restricted stock unit ("RSU") represents a contingent right to receive one ordinary share of the Issuer. Read SEC document |
| January 31, 2025 Filed Feb 4, 2025 16:51 UTC |
Smith Jason DrewGeneral Counsel
|
GrantRestricted Stock Units · Derivative | 10,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001437749-25-002685 · rdgdoc.xml · derivative · entry 10 Smith Jason Drew · CIK 0001821479 · General Counsel 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 10,000 Underlying: Ordinary Shares · 10,000 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit ("RSU") represents a contingent right to receive one ordinary share of the Issuer. F6 · derivative.exercise_date: 1/3 of the shares underlying the restricted stock units will vest on each of January 31, 2026, January 31, 2027 and January 31, 2028. F6 · derivative.expiration_date: 1/3 of the shares underlying the restricted stock units will vest on each of January 31, 2026, January 31, 2027 and January 31, 2028. Read SEC document |
| January 31, 2025 Filed Feb 4, 2025 16:51 UTC |
Smith Jason DrewGeneral Counsel
|
Exercise / conversionRestricted Stock Units · Derivative | 5,500 | $0.00 | $0.00 |
DisclosureSEC source: 0001437749-25-002685 · rdgdoc.xml · derivative · entry 9 Smith Jason Drew · CIK 0001821479 · General Counsel 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 11,000 Underlying: Ordinary Shares · 5,500 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit ("RSU") represents a contingent right to receive one ordinary share of the Issuer. F5 · derivative.exercise_date: The reporting person was granted RSUs on January 31, 2024 representing 16,500 ordinary shares. The RSUs will vest in three equal annual installments from January 31, 2025. F5 · derivative.expiration_date: The reporting person was granted RSUs on January 31, 2024 representing 16,500 ordinary shares. The RSUs will vest in three equal annual installments from January 31, 2025. Read SEC document |
| January 31, 2025 Filed Feb 4, 2025 16:51 UTC |
Smith Jason DrewGeneral Counsel
|
Exercise / conversionRestricted Stock Units · Derivative | 6,667 | $0.00 | $0.00 |
DisclosureSEC source: 0001437749-25-002685 · rdgdoc.xml · derivative · entry 8 Smith Jason Drew · CIK 0001821479 · General Counsel 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 6,667 Underlying: Ordinary Shares · 6,667 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit ("RSU") represents a contingent right to receive one ordinary share of the Issuer. F4 · derivative.exercise_date: The reporting person was granted RSUs on January 31, 2023 representing 20,000 ordinary shares. The RSUs will vest in three equal annual installments from January 31, 2024. F4 · derivative.expiration_date: The reporting person was granted RSUs on January 31, 2023 representing 20,000 ordinary shares. The RSUs will vest in three equal annual installments from January 31, 2024. Read SEC document |
| January 31, 2025 Filed Feb 4, 2025 16:51 UTC |
Smith Jason DrewGeneral Counsel
|
Exercise / conversionRestricted Stock Units · Derivative | 2,500 | $0.00 | $0.00 |
DisclosureSEC source: 0001437749-25-002685 · rdgdoc.xml · derivative · entry 7 Smith Jason Drew · CIK 0001821479 · General Counsel 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Ordinary Shares · 2,500 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit ("RSU") represents a contingent right to receive one ordinary share of the Issuer. F3 · derivative.exercise_date: The reporting person was granted RSUs on January 31, 2022 representing 7,500 ordinary shares. The RSUs will vest in three equal annual installments from January 31, 2023. F3 · derivative.expiration_date: The reporting person was granted RSUs on January 31, 2022 representing 7,500 ordinary shares. The RSUs will vest in three equal annual installments from January 31, 2023. Read SEC document |
| January 31, 2025 Filed Feb 4, 2025 16:51 UTC |
Smith Jason DrewGeneral Counsel
|
SaleOrdinary Shares | 2,767 | $11.14 | $30,824.38 |
DisclosureSEC source: 0001437749-25-002685 · rdgdoc.xml · nonDerivative · entry 6 Smith Jason Drew · CIK 0001821479 · General Counsel 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 32,514 F2 · shares: Represents shares sold to satisfy withholding tax obligations upon the settlement of restricted stock units. Read SEC document |
| January 31, 2025 Filed Feb 4, 2025 16:51 UTC |
Smith Jason DrewGeneral Counsel
|
Exercise / conversionOrdinary Shares | 5,500 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001437749-25-002685 · rdgdoc.xml · nonDerivative · entry 5 Smith Jason Drew · CIK 0001821479 · General Counsel 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 35,281 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each restricted stock unit ("RSU") represents a contingent right to receive one ordinary share of the Issuer. Read SEC document |
| January 31, 2025 Filed Feb 4, 2025 16:51 UTC |
Smith Jason DrewGeneral Counsel
|
SaleOrdinary Shares | 3,354 | $11.14 | $37,363.56 |
DisclosureSEC source: 0001437749-25-002685 · rdgdoc.xml · nonDerivative · entry 4 Smith Jason Drew · CIK 0001821479 · General Counsel 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 29,781 F2 · shares: Represents shares sold to satisfy withholding tax obligations upon the settlement of restricted stock units. Read SEC document |
| January 31, 2025 Filed Feb 4, 2025 16:51 UTC |
Smith Jason DrewGeneral Counsel
|
Exercise / conversionOrdinary Shares | 6,667 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001437749-25-002685 · rdgdoc.xml · nonDerivative · entry 3 Smith Jason Drew · CIK 0001821479 · General Counsel 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 33,135 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each restricted stock unit ("RSU") represents a contingent right to receive one ordinary share of the Issuer. Read SEC document |
| January 31, 2025 Filed Feb 4, 2025 16:51 UTC |
Smith Jason DrewGeneral Counsel
|
SaleOrdinary Shares | 1,258 | $11.14 | $14,014.12 |
DisclosureSEC source: 0001437749-25-002685 · rdgdoc.xml · nonDerivative · entry 2 Smith Jason Drew · CIK 0001821479 · General Counsel 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 26,468 F2 · shares: Represents shares sold to satisfy withholding tax obligations upon the settlement of restricted stock units. Read SEC document |
| January 31, 2025 Filed Feb 4, 2025 16:51 UTC |
Smith Jason DrewGeneral Counsel
|
Exercise / conversionOrdinary Shares | 2,500 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001437749-25-002685 · rdgdoc.xml · nonDerivative · entry 1 Smith Jason Drew · CIK 0001821479 · General Counsel 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 27,726 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each restricted stock unit ("RSU") represents a contingent right to receive one ordinary share of the Issuer. Read SEC document |
| January 31, 2025 Filed Feb 4, 2025 16:49 UTC |
Barrett Elizabeth A.Chief Executive Officer
|
GrantRestricted Stock Units · Derivative | 96,377 | $0.00 | $0.00 |
DisclosureSEC source: 0001437749-25-002683 · rdgdoc.xml · derivative · entry 1 Barrett Elizabeth A. · CIK 0001764157 · Chief Executive Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 96,377 Underlying: Ordinary Shares · 96,377 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit ("RSU") represents a contingent right to receive one ordinary share of the Issuer. F2 · derivative.exercise_date: 1/3 of the shares underlying the restricted stock units will vest on each of January 31, 2026, January 31, 2027 and January 31, 2028. F2 · derivative.expiration_date: 1/3 of the shares underlying the restricted stock units will vest on each of January 31, 2026, January 31, 2027 and January 31, 2028. Read SEC document |
| October 08, 2024 Filed Oct 9, 2024 20:22 UTC |
Degnan ChrisChief Financial Officer
|
GrantEmployee Stock Option (right to buy) · Derivative | 74,142 | $0.00 Strike: $13.11 | $0.00 |
DisclosureSEC source: 0001415889-24-024932 · form4-10092024_081051.xml · derivative · entry 2 Degnan Chris · CIK 0001741968 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 74,142 Underlying: Ordinary Shares · 74,142 shares Expires 2034-10-08 F3 · derivative.exercise_date: 1/3 of the shares underlying the stock option will vest on each of October 8, 2025, October 8, 2026 and October 8, 2027. Read SEC document |
| October 08, 2024 Filed Oct 9, 2024 20:22 UTC |
Degnan ChrisChief Financial Officer
|
GrantRestricted Stock Units · Derivative | 13,450 | $0.00 | $0.00 |
DisclosureSEC source: 0001415889-24-024932 · form4-10092024_081051.xml · derivative · entry 1 Degnan Chris · CIK 0001741968 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 13,450 Underlying: Ordinary Shares · 13,450 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit ("RSU") represents a contingent right to receive one ordinary share of the Issuer. F2 · derivative.exercise_date: 1/3 of the shares underlying the restricted stock units will vest on each of October 8, 2025, October 8, 2026 and October 8, 2027. F2 · derivative.expiration_date: 1/3 of the shares underlying the restricted stock units will vest on each of October 8, 2025, October 8, 2026 and October 8, 2027. Read SEC document |
| September 09, 2024 Filed Sep 12, 2024 17:54 UTC |
Schoenberg MarkChief Medical Officer
|
Exercise / conversionRestricted Stock Units · Derivative | 1,666 | $0.00 | $0.00 |
DisclosureSEC source: 0001437749-24-029040 · rdgdoc.xml · derivative · entry 3 Schoenberg Mark · CIK 0001763581 · Chief Medical Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 3,334 Underlying: Ordinary Shares · 1,666 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit ("RSU") represents a contingent right to receive one ordinary share of the Issuer. F3 · derivative.exercise_date: The reporting person was granted RSUs on September 7, 2023 representing 5,000 ordinary shares. The RSUs will vest in three equal annual installments from September 7, 2024. F3 · derivative.expiration_date: The reporting person was granted RSUs on September 7, 2023 representing 5,000 ordinary shares. The RSUs will vest in three equal annual installments from September 7, 2024. Read SEC document |
| September 09, 2024 Filed Sep 12, 2024 17:54 UTC |
Schoenberg MarkChief Medical Officer
|
SaleOrdinary Shares | 859 | $13.08 | $11,235.72 |
DisclosureSEC source: 0001437749-24-029040 · rdgdoc.xml · nonDerivative · entry 2 Schoenberg Mark · CIK 0001763581 · Chief Medical Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 145,091 F2 · shares: Represents shares sold to satisfy withholding tax obligations upon the settlement of restricted stock units. Read SEC document |
| September 09, 2024 Filed Sep 12, 2024 17:54 UTC |
Schoenberg MarkChief Medical Officer
|
Exercise / conversionOrdinary Shares | 1,666 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001437749-24-029040 · rdgdoc.xml · nonDerivative · entry 1 Schoenberg Mark · CIK 0001763581 · Chief Medical Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 145,950 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each restricted stock unit ("RSU") represents a contingent right to receive one ordinary share of the Issuer. Read SEC document |
| September 09, 2024 Filed Sep 12, 2024 17:51 UTC |
Smith Jason DrewGeneral Counsel
|
Exercise / conversionRestricted Stock Units · Derivative | 3,333 | $0.00 | $0.00 |
DisclosureSEC source: 0001437749-24-029038 · rdgdoc.xml · derivative · entry 3 Smith Jason Drew · CIK 0001821479 · General Counsel 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 6,667 Underlying: Ordinary Shares · 3,333 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit ("RSU") represents a contingent right to receive one ordinary share of the Issuer. F3 · derivative.exercise_date: The reporting person was granted RSUs on September 7, 2023 representing 10,000 ordinary shares. The RSUs will vest in three equal annual installments from September 7, 2024. F3 · derivative.expiration_date: The reporting person was granted RSUs on September 7, 2023 representing 10,000 ordinary shares. The RSUs will vest in three equal annual installments from September 7, 2024. Read SEC document |
| September 09, 2024 Filed Sep 12, 2024 17:51 UTC |
Smith Jason DrewGeneral Counsel
|
SaleOrdinary Shares | 1,521 | $13.08 | $19,894.68 |
DisclosureSEC source: 0001437749-24-029038 · rdgdoc.xml · nonDerivative · entry 2 Smith Jason Drew · CIK 0001821479 · General Counsel 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 25,226 F2 · shares: Represents shares sold to satisfy withholding tax obligations upon the settlement of restricted stock units. Read SEC document |
| September 09, 2024 Filed Sep 12, 2024 17:51 UTC |
Smith Jason DrewGeneral Counsel
|
Exercise / conversionOrdinary Shares | 3,333 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001437749-24-029038 · rdgdoc.xml · nonDerivative · entry 1 Smith Jason Drew · CIK 0001821479 · General Counsel 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 26,747 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each restricted stock unit ("RSU") represents a contingent right to receive one ordinary share of the Issuer. Read SEC document |
| September 09, 2024 Filed Sep 12, 2024 17:50 UTC |
Kim DongChief Financial Officer
|
Exercise / conversionRestricted Stock Units · Derivative | 2,500 | $0.00 | $0.00 |
DisclosureSEC source: 0001437749-24-029036 · rdgdoc.xml · derivative · entry 2 Kim Dong · CIK 0001920163 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 5,000 Underlying: Ordinary Shares · 2,500 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit ("RSU") represents a contingent right to receive one ordinary share of the Issuer. F2 · derivative.exercise_date: The reporting person was granted RSUs on September 7, 2023 representing 7,500 ordinary shares. The RSUs will vest in three equal annual installments from September 7, 2024. F2 · derivative.expiration_date: The reporting person was granted RSUs on September 7, 2023 representing 7,500 ordinary shares. The RSUs will vest in three equal annual installments from September 7, 2024. Read SEC document |
| September 09, 2024 Filed Sep 12, 2024 17:50 UTC |
Kim DongChief Financial Officer
|
Exercise / conversionOrdinary Shares | 2,500 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001437749-24-029036 · rdgdoc.xml · nonDerivative · entry 1 Kim Dong · CIK 0001920163 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 37,753 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each restricted stock unit ("RSU") represents a contingent right to receive one ordinary share of the Issuer. Read SEC document |
| August 06, 2024 Filed Aug 8, 2024 09:09 UTC |
Holden StuartDirector
|
GrantStock Option (right ot buy) · Derivative | 10,000 | $0.00 Strike: $15.16 | $0.00 |
DisclosureSEC source: 0001437749-24-025295 · rdgdoc.xml · derivative · entry 1 Holden Stuart · CIK 0001763999 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 10,000 Underlying: Ordinary Shares · 10,000 shares Expires 2034-08-06 F1 · derivative.exercise_date: The shares underlying the stock option will vest in equal quarterly installments over a period of one year, subject to the director's Continuous Service (as defined in the 2017 Equity Incentive Plan) through such vesting dates. Read SEC document |
| August 06, 2024 Filed Aug 8, 2024 13:11 UTC |
Belldegrun ArieDirector
|
GrantStock Option (right ot buy) · Derivative | 10,000 | $0.00 Strike: $15.16 | $0.00 |
DisclosureSEC source: 0001437749-24-025299 · rdgdoc.xml · derivative · entry 1 Belldegrun Arie · CIK 0001296549 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 10,000 Underlying: Ordinary Shares · 10,000 shares Expires 2034-08-06 F1 · derivative.exercise_date: The shares underlying the stock option will vest in equal quarterly installments over a period of one year, subject to the director's Continuous Service (as defined in the 2017 Equity Incentive Plan) through such vesting dates. Read SEC document |
| August 06, 2024 Filed Aug 8, 2024 13:11 UTC |
Cohen Fred EDirector
|
GrantStock Option (right ot buy) · Derivative | 10,000 | $0.00 Strike: $15.16 | $0.00 |
DisclosureSEC source: 0001437749-24-025298 · rdgdoc.xml · derivative · entry 1 Cohen Fred E · CIK 0001339358 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 10,000 Underlying: Ordinary Shares · 10,000 shares Expires 2034-08-06 F1 · derivative.exercise_date: The shares underlying the stock option will vest in equal quarterly installments over a period of one year, subject to the director's Continuous Service (as defined in the 2017 Equity Incentive Plan) through such vesting dates. Read SEC document |
| August 06, 2024 Filed Aug 8, 2024 13:10 UTC |
Wildman Daniel GeorgeDirector
|
GrantStock Option (right ot buy) · Derivative | 10,000 | $0.00 Strike: $15.16 | $0.00 |
DisclosureSEC source: 0001437749-24-025297 · rdgdoc.xml · derivative · entry 1 Wildman Daniel George · CIK 0001952679 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 10,000 Underlying: Ordinary Shares · 10,000 shares Expires 2034-08-06 F1 · derivative.exercise_date: The shares underlying the stock option will vest in equal quarterly installments over a period of one year, subject to the director's Continuous Service (as defined in the 2017 Equity Incentive Plan) through such vesting dates. Read SEC document |
| August 06, 2024 Filed Aug 8, 2024 13:08 UTC |
Robinson James A. Jr.Director
|
GrantStock Option (right ot buy) · Derivative | 10,000 | $0.00 Strike: $15.16 | $0.00 |
DisclosureSEC source: 0001437749-24-025293 · rdgdoc.xml · derivative · entry 1 Robinson James A. Jr. · CIK 0001734295 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 10,000 Underlying: Ordinary Shares · 10,000 shares Expires 2034-08-06 F1 · derivative.exercise_date: The shares underlying the stock option will vest in equal quarterly installments over a period of one year, subject to the director's Continuous Service (as defined in the 2017 Equity Incentive Plan) through such vesting dates. Read SEC document |
| August 06, 2024 Filed Aug 8, 2024 13:07 UTC |
WEN LEANADirector
|
GrantStock Option (right ot buy) · Derivative | 10,000 | $0.00 Strike: $15.16 | $0.00 |
DisclosureSEC source: 0001437749-24-025292 · rdgdoc.xml · derivative · entry 1 WEN LEANA · CIK 0001847598 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 10,000 Underlying: Ordinary Shares · 10,000 shares Expires 2034-08-06 F1 · derivative.exercise_date: The shares underlying the stock option will vest in equal quarterly installments over a period of one year, subject to the director's Continuous Service (as defined in the 2017 Equity Incentive Plan) through such vesting dates. Read SEC document |
| August 06, 2024 Filed Aug 8, 2024 13:06 UTC |
BUTITTA CYNTHIA MDirector
|
GrantStock Option (right ot buy) · Derivative | 10,000 | $0.00 Strike: $15.16 | $0.00 |
DisclosureSEC source: 0001437749-24-025291 · rdgdoc.xml · derivative · entry 1 BUTITTA CYNTHIA M · CIK 0001222082 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 10,000 Underlying: Ordinary Shares · 10,000 shares Expires 2034-08-06 F1 · derivative.exercise_date: The shares underlying the stock option will vest in equal quarterly installments over a period of one year, subject to the director's Continuous Service (as defined in the 2017 Equity Incentive Plan) through such vesting dates. Read SEC document |
| June 10, 2024 Filed Jun 11, 2024 17:15 UTC |
Schoenberg MarkChief Medical Officer
|
Exercise / conversionRestricted Stock Units · Derivative | 10,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001437749-24-019900 · rdgdoc.xml · derivative · entry 3 Schoenberg Mark · CIK 0001763581 · Chief Medical Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 20,000 Underlying: Ordinary Shares · 10,000 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit ("RSU") represents a contingent right to receive one ordinary share of the Issuer. F3 · derivative.exercise_date: The reporting person was granted RSUs on June 8, 2023 representing 30,000 ordinary shares. The RSUs will vest in three equal annual installments from June 8, 2024. F3 · derivative.expiration_date: The reporting person was granted RSUs on June 8, 2023 representing 30,000 ordinary shares. The RSUs will vest in three equal annual installments from June 8, 2024. Read SEC document |
| June 10, 2024 Filed Jun 11, 2024 17:15 UTC |
Schoenberg MarkChief Medical Officer
|
SaleOrdinary Shares | 5,153 | $13.08 | $67,401.24 |
DisclosureSEC source: 0001437749-24-019900 · rdgdoc.xml · nonDerivative · entry 2 Schoenberg Mark · CIK 0001763581 · Chief Medical Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 144,284 F2 · shares: Represents shares sold to satisfy withholding tax obligations upon the settlement of restricted stock units. Read SEC document |
| June 10, 2024 Filed Jun 11, 2024 17:15 UTC |
Schoenberg MarkChief Medical Officer
|
Exercise / conversionOrdinary Shares | 10,000 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001437749-24-019900 · rdgdoc.xml · nonDerivative · entry 1 Schoenberg Mark · CIK 0001763581 · Chief Medical Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 149,437 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each restricted stock unit ("RSU") represents a contingent right to receive one ordinary share of the Issuer. Read SEC document |
| March 18, 2024 Filed Mar 20, 2024 20:38 UTC |
Schoenberg MarkChief Medical Officer
|
SaleOrdinary Shares | 12,000 | $14.05 | $168,600.00 |
DisclosureSEC source: 0001437749-24-008707 · rdgdoc.xml · nonDerivative · entry 1 Schoenberg Mark · CIK 0001763581 · Chief Medical Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 139,437 F1 · shares: A portion of the cash receipts will be used for federal income tax purposes Read SEC document |
| February 01, 2024 Filed Feb 6, 2024 02:15 UTC Amendment |
Schoenberg MarkChief Medical Officer
|
SaleOrdinary Shares | 1,894 | $15.78 | $29,887.32 |
DisclosureSEC source: 0001437749-24-003153 · rdgdoc.xml · nonDerivative · entry 3 Schoenberg Mark · CIK 0001763581 · Chief Medical Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 151,437 F1 · date: This amendment corrects and restates the date of sale reported in the original Form 4 filed on February 2, 2024. F2 · price: This amendment corrects and restates the sales price reported in the original Form 4 filed on February 2, 2024. Read SEC document |
| February 01, 2024 Filed Feb 6, 2024 02:15 UTC Amendment |
Schoenberg MarkChief Medical Officer
|
SaleOrdinary Shares | 758 | $15.78 | $11,961.24 |
DisclosureSEC source: 0001437749-24-003153 · rdgdoc.xml · nonDerivative · entry 2 Schoenberg Mark · CIK 0001763581 · Chief Medical Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 149,998 F1 · date: This amendment corrects and restates the date of sale reported in the original Form 4 filed on February 2, 2024. F2 · price: This amendment corrects and restates the sales price reported in the original Form 4 filed on February 2, 2024. Read SEC document |
| February 01, 2024 Filed Feb 6, 2024 02:15 UTC Amendment |
Schoenberg MarkChief Medical Officer
|
SaleOrdinary Shares | 1,137 | $15.78 | $17,941.86 |
DisclosureSEC source: 0001437749-24-003153 · rdgdoc.xml · nonDerivative · entry 1 Schoenberg Mark · CIK 0001763581 · Chief Medical Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 149,423 F1 · date: This amendment corrects and restates the date of sale reported in the original Form 4 filed on February 2, 2024. F2 · price: This amendment corrects and restates the sales price reported in the original Form 4 filed on February 2, 2024. Read SEC document |
| February 01, 2024 Filed Feb 6, 2024 02:16 UTC Amendment |
Smith Jason DrewGeneral Counsel
|
SaleOrdinary Shares | 3,328 | $15.78 | $52,515.84 |
DisclosureSEC source: 0001437749-24-003155 · rdgdoc.xml · nonDerivative · entry 3 Smith Jason Drew · CIK 0001821479 · General Counsel 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 23,414 F1 · date: This amendment corrects and restates the date of sale reported in the original Form 4 filed on February 2, 2024. F2 · price: This amendment corrects and restates the sales price reported in the original Form 4 filed on February 2, 2024. Read SEC document |
| February 01, 2024 Filed Feb 6, 2024 02:16 UTC Amendment |
Smith Jason DrewGeneral Counsel
|
SaleOrdinary Shares | 1,248 | $15.78 | $19,693.44 |
DisclosureSEC source: 0001437749-24-003155 · rdgdoc.xml · nonDerivative · entry 2 Smith Jason Drew · CIK 0001821479 · General Counsel 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 20,076 F1 · date: This amendment corrects and restates the date of sale reported in the original Form 4 filed on February 2, 2024. F2 · price: This amendment corrects and restates the sales price reported in the original Form 4 filed on February 2, 2024. Read SEC document |
| February 01, 2024 Filed Feb 6, 2024 02:16 UTC Amendment |
Smith Jason DrewGeneral Counsel
|
SaleOrdinary Shares | 417 | $15.78 | $6,580.26 |
DisclosureSEC source: 0001437749-24-003155 · rdgdoc.xml · nonDerivative · entry 1 Smith Jason Drew · CIK 0001821479 · General Counsel 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 18,824 F1 · date: This amendment corrects and restates the date of sale reported in the original Form 4 filed on February 2, 2024. F2 · price: This amendment corrects and restates the sales price reported in the original Form 4 filed on February 2, 2024. Read SEC document |
| January 31, 2024 Filed Feb 3, 2024 00:07 UTC |
Schoenberg MarkChief Medical Officer
|
GrantRestricted Stock Units · Derivative | 10,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001437749-24-003016 · rdgdoc.xml · derivative · entry 10 Schoenberg Mark · CIK 0001763581 · Chief Medical Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 10,000 Underlying: Ordinary Shares · 10,000 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit ("RSU") represents a contingent right to receive one ordinary share of the Issuer. F6 · derivative.exercise_date: 1/3 of the shares underlying the restricted stock units will vest on each of January 31, 2025, January 31, 2026 and January 31, 2027. F6 · derivative.expiration_date: 1/3 of the shares underlying the restricted stock units will vest on each of January 31, 2025, January 31, 2026 and January 31, 2027. Read SEC document |
| January 31, 2024 Filed Feb 3, 2024 00:07 UTC |
Schoenberg MarkChief Medical Officer
|
Exercise / conversionRestricted Stock Units · Derivative | 3,333 | $0.00 | $0.00 |
DisclosureSEC source: 0001437749-24-003016 · rdgdoc.xml · derivative · entry 9 Schoenberg Mark · CIK 0001763581 · Chief Medical Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 6,667 Underlying: Ordinary Shares · 3,333 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit ("RSU") represents a contingent right to receive one ordinary share of the Issuer. F5 · derivative.exercise_date: The reporting person was granted RSUs on January 31, 2023 representing 10,000 ordinary shares. The RSUs will vest in three equal annual installments from January 31, 2024. F5 · derivative.expiration_date: The reporting person was granted RSUs on January 31, 2023 representing 10,000 ordinary shares. The RSUs will vest in three equal annual installments from January 31, 2024. Read SEC document |
| January 31, 2024 Filed Feb 3, 2024 00:07 UTC |
Schoenberg MarkChief Medical Officer
|
Exercise / conversionRestricted Stock Units · Derivative | 1,333 | $0.00 | $0.00 |
DisclosureSEC source: 0001437749-24-003016 · rdgdoc.xml · derivative · entry 8 Schoenberg Mark · CIK 0001763581 · Chief Medical Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,334 Underlying: Ordinary Shares · 1,333 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit ("RSU") represents a contingent right to receive one ordinary share of the Issuer. F4 · derivative.exercise_date: The reporting person was granted RSUs on January 31, 2022 representing 4,000 ordinary shares. The RSUs will vest in three equal annual installments from January 31, 2023. F4 · derivative.expiration_date: The reporting person was granted RSUs on January 31, 2022 representing 4,000 ordinary shares. The RSUs will vest in three equal annual installments from January 31, 2023. Read SEC document |
| January 31, 2024 Filed Feb 3, 2024 00:07 UTC |
Schoenberg MarkChief Medical Officer
|
Exercise / conversionRestricted Stock Units · Derivative | 2,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001437749-24-003016 · rdgdoc.xml · derivative · entry 7 Schoenberg Mark · CIK 0001763581 · Chief Medical Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Ordinary Shares · 2,000 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit ("RSU") represents a contingent right to receive one ordinary share of the Issuer. F3 · derivative.exercise_date: The reporting person was granted RSUs on January 31, 2021 representing 6,000 ordinary shares. The RSUs will vest in three equal annual installments from January 31, 2022. F3 · derivative.expiration_date: The reporting person was granted RSUs on January 31, 2021 representing 6,000 ordinary shares. The RSUs will vest in three equal annual installments from January 31, 2022. Read SEC document |
| January 31, 2024 Filed Feb 3, 2024 00:07 UTC |
Schoenberg MarkChief Medical Officer
|
SaleOrdinary Shares | 1,894 | $15.74 | $29,811.56 |
DisclosureSEC source: 0001437749-24-003016 · rdgdoc.xml · nonDerivative · entry 6 Schoenberg Mark · CIK 0001763581 · Chief Medical Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 151,437 F2 · shares: Represents shares sold to satisfy withholding tax obligations upon the settlement of restricted stock units. Read SEC document |
| January 31, 2024 Filed Feb 3, 2024 00:07 UTC |
Schoenberg MarkChief Medical Officer
|
Exercise / conversionOrdinary Shares | 3,333 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001437749-24-003016 · rdgdoc.xml · nonDerivative · entry 5 Schoenberg Mark · CIK 0001763581 · Chief Medical Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 153,331 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each restricted stock unit ("RSU") represents a contingent right to receive one ordinary share of the Issuer. Read SEC document |
| January 31, 2024 Filed Feb 3, 2024 00:07 UTC |
Schoenberg MarkChief Medical Officer
|
SaleOrdinary Shares | 758 | $15.74 | $11,930.92 |
DisclosureSEC source: 0001437749-24-003016 · rdgdoc.xml · nonDerivative · entry 4 Schoenberg Mark · CIK 0001763581 · Chief Medical Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 149,998 F2 · shares: Represents shares sold to satisfy withholding tax obligations upon the settlement of restricted stock units. Read SEC document |
| January 31, 2024 Filed Feb 3, 2024 00:07 UTC |
Schoenberg MarkChief Medical Officer
|
Exercise / conversionOrdinary Shares | 1,333 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001437749-24-003016 · rdgdoc.xml · nonDerivative · entry 3 Schoenberg Mark · CIK 0001763581 · Chief Medical Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 150,756 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each restricted stock unit ("RSU") represents a contingent right to receive one ordinary share of the Issuer. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.